DMXAA (ASA-404; Vadimezan;NSC 640488); 5,6-Dimethylxantheonone-4-acetic acid

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
25 mg	In-stock	$236.00	Visible after login	- +
50 mg	In-stock	$426.00	Visible after login	- +
100 mg	In-stock	$466.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

25 mg

In-stock

$236.00

Visible after login

- +

50 mg

In-stock

$426.00

Visible after login

- +

100 mg

In-stock

$466.00

Visible after login

- +

Product Overview

Product Name	Vadimezan (Synonyms: DMXAA; ASA-404)
CAS	117570-53-3
Formula	C17H14O4
MW	282.29
MDL	MFCD00870555
Appearance	Light brown powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Vadimezan, also known as DMXAA and ASA404, is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL1889

Vadimezan (Synonyms: DMXAA; ASA-404)

117570-53-3 98+%

CL1312A

Frovatriptan Succinate Monohydrate (Synonyms: Frovatriptan succinate hydrate;(R)-Frovatriptan succinate hydrate; SB 209509 succinate hydrate; VML 251 succinate hydrate)

158930-17-7 98+%

Vadimezan (Synonyms: DMXAA; ASA-404)

Chemical safety data sheet(MSDS)

Certificate Of Authenticity(CPA)